{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:15:53Z","timestamp":1794492953685,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"crossref","award":["R44ES027703"],"award-info":[{"award-number":["R44ES027703"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"crossref","award":["R44ES027703"],"award-info":[{"award-number":["R44ES027703"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"crossref","award":["R44ES027703"],"award-info":[{"award-number":["R44ES027703"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"crossref","award":["R44ES027703"],"award-info":[{"award-number":["R44ES027703"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"crossref","award":["R44ES027703"],"award-info":[{"award-number":["R44ES027703"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The immature phenotype of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) is a major limitation to the use of these valuable cells for pre-clinical toxicity testing and for disease modeling. Here we tested the hypothesis that human perinatal stem cell derived extracellular matrix (ECM) promotes hiPSC-CM maturation to a greater extent than mouse cell derived ECM. We refer to the human ECM as Matrix Plus (Matrix Plus) and compare effects to commercially available mouse ECM (Matrigel). hiPSC-CMs cultured on Matrix Plus mature functionally and structurally seven days after thaw from cryopreservation. Mature hiPSC-CMs showed rod-shaped morphology, highly organized sarcomeres, elevated cTnI expression and mitochondrial distribution and function like adult cardiomyocytes. Matrix Plus also promoted mature hiPSC-CM electrophysiological function and monolayers\u2019 response to hERG ion channel specific blocker was Torsades de Pointes (TdP) reentrant arrhythmia activations in 100% of tested monolayers. Importantly, Matrix Plus enabled high throughput cardiotoxicity screening using mature human cardiomyocytes with validation utilizing reference compounds recommended for the evolving Comprehensive In Vitro Proarrhythmia Assay (CiPA) coordinated by the Health and Environmental Sciences Institute (HESI). Matrix Plus offers a solution to the commonly encountered problem of hiPSC-CM immaturity that has hindered implementation of these human based cell assays for pre-clinical drug discovery.<\/jats:p>","DOI":"10.1038\/s41598-020-76052-y","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T11:03:36Z","timestamp":1604487816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes"],"prefix":"10.1038","volume":"10","author":[{"given":"Travis","family":"Block","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Creech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Monteiro","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Marinkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ponce-Balbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric N.","family":"Jim\u00e9nez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sy","family":"Griffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Herron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"76052_CR1","doi-asserted-by":"publisher","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","volume":"301","author":"J Ma","year":"2011","unstructured":"Ma, J. et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart Circ. Physiol. 301, H2006\u2013H2017 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"76052_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrd.2015.34","volume":"15","author":"G Gintant","year":"2016","unstructured":"Gintant, G., Sager, P. T. & Stockbridge, N. Evolution of strategies to improve preclinical cardiac safety testing. Nat. Rev. Drug Discov. 15, 457 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76052_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge, P. W. et al. Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes. Nat. Methods 11, 855\u2013860 (2014).","journal-title":"Nat. Methods"},{"key":"76052_CR4","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1038\/s41596-018-0076-8","volume":"13","author":"A Sharma","year":"2018","unstructured":"Sharma, A. et al. Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nat. Protoc. 13, 3018\u20133041 (2018).","journal-title":"Nat. Protoc."},{"key":"76052_CR5","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","volume":"24","author":"K Blinova","year":"2018","unstructured":"Blinova, K. et al. International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment. Cell Rep. 24, 3582\u20133592 (2018).","journal-title":"Cell Rep."},{"key":"76052_CR6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/2472555218775028","volume":"23","author":"B Fermini","year":"2018","unstructured":"Fermini, B., Coyne, S. T. & Coyne, K. P. Clinical trials in a dish: a perspective on the coming revolution in drug development. SLAS Discov. Adv. Life Sci. R&D 23, 765\u2013776 (2018).","journal-title":"SLAS Discov. Adv. Life Sci. R&D"},{"key":"76052_CR7","first-page":"687","volume":"12","author":"K Blinova","year":"2019","unstructured":"Blinova, K. et al. Clinical trial in a dish: personalized stem cell-derived cardiomyocyte assay compared with clinical trial results for two QT-prolonging drugs. Morb. Mortal. Wkly.. 12, 687\u2013697 (2019).","journal-title":"Morb. Mortal. Wkly.."},{"key":"76052_CR8","doi-asserted-by":"publisher","first-page":"010901","DOI":"10.1063\/1.5070106","volume":"3","author":"RJ Mills","year":"2019","unstructured":"Mills, R. J. & Hudson, J. E. Bioengineering adult human heart tissue: How close are we?. Al. Bioeng. 3, 010901 (2019).","journal-title":"Al. Bioeng."},{"key":"76052_CR9","doi-asserted-by":"crossref","unstructured":"Karbassi, E. et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat. Rev. Cardiol. (2020).","DOI":"10.1038\/s41569-019-0331-x"},{"key":"76052_CR10","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1089\/scd.2012.0490","volume":"22","author":"SD Lundy","year":"2013","unstructured":"Lundy, S. D., Zhu, W. Z., Regnier, M. & Laflamme, M. A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 22, 1991\u20132002 (2013).","journal-title":"Stem Cells Dev."},{"key":"76052_CR11","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","volume":"134","author":"JL Ruan","year":"2016","unstructured":"Ruan, J. L. et al. Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134, 1557\u20131567 (2016).","journal-title":"Circulation"},{"key":"76052_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.cell.2018.11.042","volume":"176","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. A platform for generation of chamber-specific cardiac tissues and disease modeling. Cell 176, 913-927.e918 (2019).","journal-title":"Cell"},{"key":"76052_CR13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.117.311920","volume":"121","author":"SS Parikh","year":"2017","unstructured":"Parikh, S. S. et al. Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 121, 1323\u20131330 (2017).","journal-title":"Circ. Res."},{"key":"76052_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.healun.2017.01.001","volume":"36","author":"J Pasquier","year":"2017","unstructured":"Pasquier, J. et al. Coculturing with endothelial cells promotes in vitro maturation and electrical coupling of human embryonic stem cell-derived cardiomyocytes. J. Heart Lung. Transpl. 36, 684\u2013693 (2017).","journal-title":"J. Heart Lung. Transpl."},{"key":"76052_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/stem.2732","volume":"36","author":"OJ Abilez","year":"2018","unstructured":"Abilez, O. J. et al. Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling. Stem Cells 36, 265\u2013277 (2018).","journal-title":"Stem Cells"},{"key":"76052_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nmeth.2524","volume":"10","author":"SS Nunes","year":"2013","unstructured":"Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell\u2013derived cardiomyocytes. Nat. Methods 10, 781 (2013).","journal-title":"Nat. Methods"},{"key":"76052_CR17","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.5966\/sctm.2016-0016","volume":"5","author":"G Jiang","year":"2016","unstructured":"Jiang, G. et al. Human cardiomyocytes prior to birth by integration-free reprogramming of amniotic fluid cells. Stem Cells Transl. Med. 5, 1595\u20131606 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"76052_CR18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1359\/jbmr.070725","volume":"22","author":"XD Chen","year":"2007","unstructured":"Chen, X. D., Dusevich, V., Feng, J. Q., Manolagas, S. C. & Jilka, R. L. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J. Bone Miner. Res. 22, 1943\u20131956 (2007).","journal-title":"J. Bone Miner. Res."},{"key":"76052_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jprot.2013.05.004","volume":"86","author":"LE de Castro Br\u00e1s","year":"2013","unstructured":"de Castro Br\u00e1s, L. E. et al. Texas 3-step decellularization protocol: looking at the cardiac extracellular matrix. J. Proteom. 86, 43\u201352 (2013).","journal-title":"J. Proteom."},{"key":"76052_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.matbio.2016.01.004","volume":"52\u201354","author":"M Marinkovic","year":"2016","unstructured":"Marinkovic, M. et al. One size does not fit all: developing a cell-specific niche for in vitro study of cell behavior. Matrix Biol. 52\u201354, 426\u2013441 (2016).","journal-title":"Matrix Biol."},{"key":"76052_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biomaterials.2017.03.008","volume":"128","author":"H Ragelle","year":"2017","unstructured":"Ragelle, H. et al. Comprehensive proteomic characterization of stem cell-derived extracellular matrices. Biomaterials 128, 147\u2013159 (2017).","journal-title":"Biomaterials"},{"key":"76052_CR22","doi-asserted-by":"publisher","first-page":"13834","DOI":"10.1038\/s41598-017-13590-y","volume":"7","author":"AM da Rocha","year":"2017","unstructured":"da Rocha, A. M. et al. hiPSC-CM monolayer maturation state determines drug responsiveness in high throughput pro-arrhythmia screen. Sci. Rep. 7, 13834 (2017).","journal-title":"Sci. Rep."},{"key":"76052_CR23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.scr.2013.09.003","volume":"11","author":"A Bizy","year":"2013","unstructured":"Bizy, A. et al. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes. Stem Cell Res. 11, 1335\u20131347 (2013).","journal-title":"Stem Cell Res."},{"key":"76052_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/toxsci\/kfz235","volume":"173","author":"AM da Rocha","year":"2020","unstructured":"da Rocha, A. M., Creech, J., Thonn, E., Mironov, S. & Herron, T. J. Detection of drug-induced torsades de pointes arrhythmia mechanisms using hiPSC-CM syncytial monolayers in a high-throughput screening voltage sensitive dye assay. Toxicol. Sci. 173, 402\u2013415 (2020).","journal-title":"Toxicol. Sci."},{"key":"76052_CR25","doi-asserted-by":"publisher","first-page":"e003638","DOI":"10.1161\/CIRCEP.113.003638","volume":"9","author":"TJ Herron","year":"2016","unstructured":"Herron, T. J. et al. Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function. Circul. Arrhythmia Electrophysiol. 9, e003638 (2016).","journal-title":"Circul. Arrhythmia Electrophysiol."},{"key":"76052_CR26","doi-asserted-by":"publisher","first-page":"H1357","DOI":"10.1152\/ajpheart.00481.2019","volume":"318","author":"H Musa","year":"2020","unstructured":"Musa, H. et al. Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk. Am. J. Physiol. Heart Circ. Physiol. 318, H1357\u2013H1370 (2020).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"76052_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/bdrc.20171","volume":"90","author":"XD Chen","year":"2010","unstructured":"Chen, X. D. Extracellular matrix provides an optimal niche for the maintenance and propagation of mesenchymal stem cells. Birth Defects Res. C Embryo. Today 90, 45\u201354 (2010).","journal-title":"Birth Defects Res. C Embryo. Today"},{"key":"76052_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10059-011-2277-7","volume":"32","author":"DC Andersen","year":"2011","unstructured":"Andersen, D. C. et al. Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells. Mol. Cells 32, 133\u2013142 (2011).","journal-title":"Mol. Cells"},{"key":"76052_CR29","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/ncomms2964","volume":"4","author":"A Urciuolo","year":"2013","unstructured":"Urciuolo, A. et al. Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat. Commun. 4, 1964 (2013).","journal-title":"Nat. Commun."},{"key":"76052_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1476-5381.2011.01558.x","volume":"165","author":"L Nalos","year":"2012","unstructured":"Nalos, L. et al. Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes. Br. J. Pharmacol. 165, 467\u2013478 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"76052_CR31","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sj.bjp.0707513","volume":"152","author":"G Michael","year":"2007","unstructured":"Michael, G., Dempster, J., Kane, K. A. & Coker, S. J. Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation. Br. J. Pharmacol. 152, 1215\u20131227 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"76052_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/00498250110054632","volume":"31","author":"R Webster","year":"2001","unstructured":"Webster, R. et al. Pharmacokinetic\/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog. Xenobiotica 31, 633\u2013650 (2001).","journal-title":"Xenobiotica"},{"key":"76052_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jphs.2018.06.005","volume":"137","author":"A Goto","year":"2018","unstructured":"Goto, A. et al. Analysis of torsadogenic and pharmacokinetic profile of E-4031 in dogs bridging the gap of information between in vitro proarrhythmia assay and clinical observation in human subjects. J. Pharmacol. Sci. 137, 237\u2013240 (2018).","journal-title":"J. Pharmacol. Sci."},{"key":"76052_CR34","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.119.315862","volume":"126","author":"Y Guo","year":"2020","unstructured":"Guo, Y. & Pu, W. T. Cardiomyocyte maturation: new phase in development. Circ. Res. 126, 1086\u20131106 (2020).","journal-title":"Circ. Res."},{"key":"76052_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nmat3937","volume":"13","author":"WL Murphy","year":"2014","unstructured":"Murphy, W. L., McDevitt, T. C. & Engler, A. J. Materials as stem cell regulators. Nat. Mater. 13, 547\u2013557 (2014).","journal-title":"Nat. Mater."},{"key":"76052_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1161\/CIRCRESAHA.115.307580","volume":"117","author":"TK Feaster","year":"2015","unstructured":"Feaster, T. K. et al. Matrigel mattress: a method for the generation of single contracting human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 117, 995\u20131000 (2015).","journal-title":"Circ. Res."},{"key":"76052_CR37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1083\/jcb.147.5.1109","volume":"147","author":"M Costell","year":"1999","unstructured":"Costell, M. et al. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell. Biol. 147, 1109\u20131122 (1999).","journal-title":"J. Cell. Biol."},{"key":"76052_CR38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.matbio.2018.02.013","volume":"68\u201369","author":"MS Lord","year":"2018","unstructured":"Lord, M. S. et al. The multifaceted roles of perlecan in fibrosis. Matrix Biol. 68\u201369, 150\u2013166 (2018).","journal-title":"Matrix Biol."},{"key":"76052_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.matbio.2016.09.003","volume":"57\u201358","author":"MA Gubbiotti","year":"2017","unstructured":"Gubbiotti, M. A., Neill, T. & Iozzo, R. V. A current view of perlecan in physiology and pathology: a mosaic of functions. Matrix Biol. 57\u201358, 285\u2013298 (2017).","journal-title":"Matrix Biol."},{"key":"76052_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","volume":"556","author":"K Ronaldson-Bouchard","year":"2018","unstructured":"Ronaldson-Bouchard, K. et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556, 239\u2013243 (2018).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76052-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:25:42Z","timestamp":1670365542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76052-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76052"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76052-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.B., is employee of StemBioSys, Inc. J.C., A.M.R. are consultants for Cartox, Inc. T.J.H. is co-founder of Cartox, Inc. and consultant to StemBioSys, Inc. All other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19071"}}